Role of miRNA-495 and NRXN-1 and CNTN-1 mRNA Expression and Its Prognostic Importance in Breast Cancer Patients

Table 2

Association of miRNA-495 expression in breast cancer cases with different clinicopathological features.

Variables	miRNA-495 expression		value
	Mean	SD
Relative expression	0.07	0.05	—
Age
≤50 years	0.09	0.11	0.02
>50 years	0.04	0.02
Menopause
Yes	0.04	0.03	0.0001
No	0.12	0.12
Lymph nodes
Yes	0.07	0.10	0.21
No	0.07	0.07
ER status
Yes	0.05	0.04	0.10
No	0.09	0.10
PR status
Yes	0.05	0.05	0.11
No	0.08	0.09
HER2 status
Yes	0.05	0.04	0.49
No	0.08	0.10
TNM stages
Early stage (I & II)	0.12	0.11	0.02
Advanced stage (III & IV)	0.05	0.03
Distant metastases
Yes	0.04	0.02	0.27
No	0.08	0.09